SCHEMBL2059632

SCHEMBL2059632

Cc1cccc(N(c2ccccc2)c2ccc(N(c3ccc(N(c4ccccc4)c4cccc(C)c4)cc3)c3cccc(N(c4ccccc4)c4cccc(C)c4)c3)cc2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.46
TDP1 Q9NUW8 3/20 0.46
CYP3A4 P08684 3/20 0.46
CYP2C9 P11712 3/20 0.46
CYP2C19 P33261 3/20 0.46
MAPT P10636 3/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
CYP1A2 P05177 2/20 0.46
KDM4E B2RXH2 1/20 0.46
CYP2D6 P10635 1/20 0.46
ACHE P22303 4/20 0.46
NPSR1 Q6W5P4 1/20 0.42
LMNA P02545 2/20 0.42
TSHR P16473 1/20 0.42
ALOX12 P18054 1/20 0.42
RAB9A P51151 3/20 0.41
NPC1 O15118 2/20 0.41
JAK2 O60674 1/20 0.41
HTT P42858 1/20 0.41
PAX8 Q06710 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10065562 1.00 ALDH1A1 (0.46) ALDH1A1TDP1CYP3A4CYP2C9CYP2C19
SCHEMBL10065954 1.00 ALDH1A1 (0.46) ALDH1A1TDP1CYP3A4CYP2C9CYP2C19
SCHEMBL10039954 0.98 ALDH1A1 (0.48) ALDH1A1TDP1CYP3A4CYP2C9CYP2C19
SCHEMBL13017732 0.98 ALDH1A1 (0.48) ALDH1A1TDP1CYP3A4CYP2C9CYP2C19
SCHEMBL26563 0.98 ALDH1A1 (0.48) ALDH1A1TDP1CYP3A4CYP2C9CYP2C19
SCHEMBL8765594 0.98 ACHE (0.48) ALDH1A1TDP1CYP3A4CYP2C9CYP2C19
SCHEMBL10065551 0.98 ALDH1A1 (0.48) ALDH1A1TDP1CYP3A4CYP2C9CYP2C19
SCHEMBL13886460 0.98 ALDH1A1 (0.48) ALDH1A1TDP1CYP3A4CYP2C9CYP2C19
SCHEMBL22812841 0.98 ALDH1A1 (0.48) ALDH1A1TDP1CYP3A4CYP2C9CYP2C19
SCHEMBL13844494 0.98 ALDH1A1 (0.48) ALDH1A1TDP1CYP3A4CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023195482-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE 出光興産株式会社 2023-10-12 WO disclosed
US-20220388989-A1 LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2022-12-08 US disclosed
US-20110063267-A1 ORGANIC LIGHT EMITTING DISPLAY DEVICE LG DISPLAY CO., LTD. (KR) 2011-03-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220388989-A1 LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE CRY1, CRY2, NQO1 ALDH1A1 18/4885TDP1 3502/4885CYP3A4 40/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.